HemaSphere (Oct 2022)

T087: Brentuximab vedotin (Bv) Demonstrates Superior Event-Free Survival in Pediatric High-Risk Hodgkin Lymphoma

  • Sharon M. Castellino,
  • Qinglin Pei,
  • Susan K. Parsons,
  • David Hodgson,
  • Kathleen Mccarten,
  • Terzah Horton,
  • Steve Cho,
  • Yue Wu,
  • Angela Punnett,
  • Hema Dave,
  • Tara O. Henderson,
  • Bradford S. Hoppe,
  • Ann-Marie Charpentier,
  • Frank G. Keller,
  • Kara M. Kelly

DOI
https://doi.org/10.1097/01.HS9.0000890916.12776.84
Journal volume & issue
Vol. 6
pp. 40 – 40

Abstract

Read online

No abstracts available.